Experts at Duke Health were among a multi-national team involved in treating a fetus for infantile-onset Pompe disease using an enzyme replacement therapy – a first in the world.

Non-Hispanic Black patients are less likely to receive guideline-appropriate treatment for ovarian cancer than non-Hispanic White patients, significantly affecting their treatment quality and survival chances.

Driving force behind strange NC outbreak solved by a Duke collaboration

People commonly associate heart attacks with clogged arteries, fatty diets, high cholesterol, and plaque buildup in the heart. And while all those things can cause sudden cardiac death, they are not the only culprit; gene mutations can also be to blame.

A study led by Duke Health researchers provides some insights: Females, it turns out, have an advantage at the molecular level that protects them from a form of cell death that occurs in injured kidneys. This protection could be exploited as a potential therapeutic.

New tool provides a framework to identify human genetic determinants of infectious disease outcomes.

Operation Deep Dive is a partnership between Duke School of Medicine and American Warrior Project to examine the factors and causes of suicide among veterans and former service members.

NC-PAL is a free provider-to-provider consultation line and education program available to all clinicians across the state for questions about behavioral health or psychiatric medication management for their pediatric and perinatal patients. Nicole Heilbron and Gary Maslow are leads of the program, part of the statewide effort to address the youth mental health crisis.

A study comparing two approaches for diagnosing heart disease found that a risk analysis strategy is superior to the usual approach of immediately performing functional tests or catheterization for low- to intermediate-risk patients with new-onset chest pain.

An estimated 6.2 million Americans ages 65 and older are living with Alzheimer's disease.